Skip to content
DxNow, Inc. logo — The future of fertility is simplicity. Innovative sperm sepa...

DxNow, Inc.

The future of fertility is simplicity. Innovative sperm separation devices - better for your patients & your practice.

Founded 2013 United States Gaithersburg, United States 4 employees Equity Crowdfunding Total: $172.50K Biotechnology, Health Care

General Information

Company Name DxNow, Inc.
Founded Year 2013
Location United States Gaithersburg, United States
Founders / Decision Makers
Team member Team member
Employees 4
Industries Biotechnology, Health Care
Funding Stage Equity Crowdfunding
Social

BounceWatch is an independent company data service, not affiliated with DxNow, Inc.. To contact DxNow, Inc., visit dxnow.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does DxNow, Inc. compare?

A PDF of DxNow, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting DxNow, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About DxNow, Inc.

DxNow, Inc. is at the forefront of simplifying fertility treatments with its innovative sperm separation devices, promoting a patient-centric approach in healthcare. With the slogan, "The future of fertility is simplicity," the company is paving new pathways in biotechnology and healthcare by integrating cutting-edge, portable bio-imaging systems with microfluidic-based consumables.

Founded in 2013, DxNow leverages technologies developed at prestigious institutions such as the Demirci Bio-Acoustic MEMS in Medicine Labs at Harvard Medical School/Brigham & Women’s Hospital and Stanford Medicine. Positioned in Montgomery County, Maryland, their headquarters benefit from a strategic location near key federal agencies like the USFDA and NIH, which aligns well with their business directions.

This privately held Delaware C corporation was last financially backed through an Equity Crowdfunding campaign on August 21, 2015. Despite the absence of disclosed investors in this round, the company's pioneering potential in life sciences continues to be its most compelling investment proposition.

Business keywords: sperm separation, fertility technology, bio-imaging systems, microfluidic consumables, reproductive endocrinology, forensic science, sexual assault evidence processing, differential extraction, assisted reproduction technology, portable diagnostic systems, rapid DNA analysis, high throughput automation, veterinary fertility applications, point of care diagnostics, molecular quantification

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Equity Crowdfunding Undisclosed -
21 Aug 2015
Debt Financing $172.50K -
02 Sep 2014

DxNow, Inc. Alternatives & Competitors

View All Alternatives
DxNow, Inc. vs

Applying innovative science to enhance egg quality and increase IVF success through proprietary tech...

Post-IPO Equity
Biotechnology, Health Care
DxNow, Inc. vs

Empowering life science and medical research through advanced genetic testing medical devices and in...

Series C
17 employees
Biotechnology, Health Care
DxNow, Inc. vs
Apollon
Apollon Korea South

The wearable that reads your glucose

Seed
40 employees
Biotechnology, Health Care

FAQ About DxNow, Inc.

The future of fertility is simplicity. Innovative sperm separation devices - better for your patients & your practice.
DxNow, Inc. was founded in 2013.
DxNow, Inc. is headquartered in Gaithersburg, United States.
DxNow, Inc. operates in Biotechnology and Health Care. Its work centres on sperm separation, fertility technology, bio-imaging systems and microfluidic consumables.
DxNow, Inc. has approximately 4 employees.
DxNow, Inc. has completed 2 funding rounds, raising a total of $172.50K. The latest funding stage is Equity Crowdfunding.
Top alternatives and competitors to DxNow, Inc. include OvaScience, 杭州联川生物技术股份有限公司, Apollon, BestHealth4U, MNCHIP. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DxNow, Inc. and OvaScience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DxNow, Inc., https://www.bouncewatch.com/company/dxnow, updated 2 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout